CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis

References

• Agid, O., Arenovich, T., Sajeev, G., Zipursky, R. B., Kapur, S., Foussias, G., & Remington, G. (2011). An algorithm-based approach to first-episode schizophrenia: Response rates over 3 prospective antipsychotic trials with a retrospective data analysis. The Journal of Clinical Psychiatry, 72(11), 1439–1444. https://doi.org/10.4088/JCP.09m05785yel
   PubMed Web of Science ®Google Scholar
• Andreasen, N. C., & Olsen, S. (1982). Negative v positive schizophrenia. Definition and validation. Archives of General Psychiatry, 39(7), 789–794. https://doi.org/10.1001/archpsyc.1982.04290070025006
   PubMed Web of Science ®Google Scholar
• Bighelli, I., Huhn, M., Schneider-Thoma, J., Krause, M., Reitmeir, C., Wallis, S., Schwermann, F., Pitschel-Walz, G., Barbui, C., Furukawa, T. A., & Leucht, S. (2018). Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: A systematic review and single-group meta-analysis. BMC Psychiatry, 18(1), 1–10. https://doi.org/10.1186/s12888-018-1964-8
   PubMedGoogle Scholar
• Booth, A., Clarke, M., Dooley, G., Ghersi, D., Moher, D., Petticrew, M., & Stewart, L. (2012). The nuts and bolts of PROSPERO: An international prospective register of systematic reviews. Systematic Reviews, 1(1), 2. https://doi.org/10.1186/2046-4053-1-2
   PubMedGoogle Scholar
• de Paiva Barretto, E. M., Kayo, M., Avrichir, B. S., Sa, A. R., Camargo, M. d G. M., Napolitano, I. C., Nery, F. G., Pinto, J. A., Jr, Bannwart, S., & Scemes, S. (2009). A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia. The Journal of Nervous and Mental Disease, 197(11), 865–868.
   PubMed Web of Science ®Google Scholar
• Gaudiano, B. A., & Herbert, J. D. (2006). Believability of hallucinations as a potential mediator of their frequency and associated distress in psychotic inpatients. Behavioural and Cognitive Psychotherapy, 34(04), 497–502. https://doi.org/10.1017/S1352465806003080
   Google Scholar
• Haddock, G., McCarron, J., Tarrier, N., & Faragher, E. (1999). Scales to measure dimensions of hallucinations and delusions: The psychotic symptom rating scales (PSYRATS). Psychological Medicine, 29(4), 879–889. https://doi.org/10.1017/s0033291799008661
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savović, J., Schulz, K. F., Weeks, L., & Sterne, J. A. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 343(2), d5928–d5928. https://doi.org/10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions. (Vol. 4). John Wiley & Sons.
   Google Scholar
• Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., Castle, D. J., Citrome, L., Daskalakis, Z. J., Davidson, M., Drake, R. J., Dursun, S., Ebdrup, B. H., Elkis, H., Falkai, P., … Correll, C. U. (2017). Treatment-resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. American Journal of Psychiatry, 174(3), 216–229. https://doi.org/10.1176/appi.ajp.2016.16050503
   PubMed Web of Science ®Google Scholar
• Jauhar, S., McKenna, P., Radua, J., Fung, E., Salvador, R., & Laws, K. (2014). Cognitive–behavioural therapy for the symptoms of schizophrenia: Systematic review and meta-analysis with examination of potential bias. British Journal of Psychiatry, 204(1), 20–29. https://doi.org/10.1192/bjp.bp.112.116285
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. https://doi.org/10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• Klingberg, S., Herrlich, J., Wiedemann, G., Wölwer, W., Meisner, C., Engel, C., Jakobi-Malterre, U. E., Buchkremer, G., & Wittorf, A. (2012). Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: Results of the treatment of negative symptoms study. The Journal of Nervous and Mental Disease, 200(7), 569–576. https://doi.org/10.1097/NMD.0b013e31825bfa1d
   PubMed Web of Science ®Google Scholar
• Land, R., Siskind, D., Mcardle, P., Kisely, S., Winckel, K., & Hollingworth, S. A. (2017). The impact of clozapine on hospital use: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 135(4), 296–309. https://doi.org/10.1111/acps.12700
   PubMed Web of Science ®Google Scholar
• Morrison, A. P., Pyle, M., Gumley, A., Schwannauer, M., Turkington, D., MacLennan, G., Norrie, J., Hudson, J., Bowe, S. E., French, P., Byrne, R., Syrett, S., Dudley, R., McLeod, H. J., Griffiths, H., Barnes, T. R. E., Davies, L., Kingdon, D., Aydinlar, S., … Tully, S. (2018). Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): An assessor-blinded, randomised controlled trial. The Lancet Psychiatry, 5(8), 633–643. https://doi.org/10.1016/S2215-0366(18)30184-6
   PubMed Web of Science ®Google Scholar
• Oakley, P., Kisely, S., Baxter, A., Harris, M., Desoe, J., Dziouba, A., & Siskind, D. (2018). Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysis. Journal of Psychiatric Research, 102, 245–253. https://doi.org/10.1016/j.jpsychires.2018.04.019
   PubMed Web of Science ®Google Scholar
• Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10(3), 799–812.
   Web of Science ®Google Scholar
• Pinto, A., Pia, S. L., Mennella, R., Giorgio, D., & DeSimone, L. (1999). Rehab rounds: Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia. Psychiatric Services, 50(7), 901–904. https://doi.org/10.1176/ps.50.7.901
   PubMed Web of Science ®Google Scholar
• Siskind, D. J., Lee, M., Ravindran, A., Zhang, Q., Ma, E., Motamarri, B., & Kisely, S. (2018). Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis. The Australian and New Zealand Journal of Psychiatry, 52(8), 751–767. https://doi.org/10.1177/0004867418772351
   PubMed Web of Science ®Google Scholar
• Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016). Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: Systematic review and meta-analysis. The British Journal of Psychiatry: The Journal of Mental Science, 209(5), 385–392. https://doi.org/10.1192/bjp.bp.115.177261
   PubMed Web of Science ®Google Scholar
• Siskind, D., Siskind, V., & Kisely, S. (2017). Clozapine response rates among people with treatment-resistant schizophrenia: Data from a systematic review and meta-analysis. Canadian Journal of Psychiatry, 62(11), 772–777.
   PubMed Web of Science ®Google Scholar
• Turner, D. T., van der Gaag, M., Karyotaki, E., & Cuijpers, P. (2014). Psychological interventions for psychosis: A meta-analysis of comparative outcome studies. The American Journal of Psychiatry, 171(5), 523–538. https://doi.org/10.1176/appi.ajp.2013.13081159
   PubMed Web of Science ®Google Scholar
• Valmaggia, L. R., Van Der Gaag, M., Tarrier, N., Pijnenborg, M., & Slooff, C. J. (2005). Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. The British Journal of Psychiatry: The Journal of Mental Science, 186(4), 324–330. https://doi.org/10.1192/bjp.186.4.324
   PubMedGoogle Scholar
• Wagner, E., Löhrs, L., Siskind, D., Honer, W. G., Falkai, P., & Hasan, A. (2019). Clozapine augmentation strategies – A systematic meta-review of available evidence. Treatment options for clozapine resistance. Journal of Psychopharmacology, 33(4), 423–435. https://doi.org/10.1177/0269881118822171
   PubMed Web of Science ®Google Scholar
• Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34(3), 523–537. https://doi.org/10.1093/schbul/sbm114
   PubMed Web of Science ®Google Scholar